Phase 4 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are scheduled for any type of mastectomy, with or without removal of lymph nodes from the armpit area
- People who agree to receive a nerve-numbing injection (called a peripheral nerve block) as part of their care
- People who agree to take part in the study
- People whose pain management team has reviewed their medical and surgical history and determined that a nerve block would be appropriate for them
- People whose surgeon agrees with the nerve block plan proposed by the pain management team
Who may not be able to join:
- People who do not wish to have a nerve block
- People who do not wish to take part in the study
- People whose pain management team determines that a nerve block is not the right option for them medically
- People whose surgeon does not want a nerve block to be used
- People who have a known allergy to local anaesthetic medications
- People who have an active infection at the area of the body where the nerve block would be given
- People who already have existing nerve damage or nerve-related symptoms in the area where the block would be applied
- People who have a condition that affects blood clotting
- People who are taking blood-thinning medications in a way that falls outside established safety guidelines (confirm with trial site)
- People who weigh less than 50 kg, due to safety concerns related to the anaesthetic medication used
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 757-953-3238
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Is bupivacaine with dexmedetomidine superior to liposomal bupivacaine in both density and duration?
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.